Browse by author
Lookup NU author(s): Professor Farhad Kamali
Full text for this publication is not currently held within this repository. Alternative links are provided below where available.
Coumarins are the mainstay of oral anticoagulation for the treatment and prophylaxis of thromboembolic disorders. They have a narrow therapeutic index and regular monitoring is therefore required to avoid serious adverse effects. There is wide interindividual variability in dosage requirements, which makes anticoagulation response unpredictable. Current dosing titrations are haphazard and inconvenient and poor initial control leads to morbidity, and occasional mortality, because of bleeding and further thromboembolism. Recent discoveries have helped to characterize the factors that contribute to the interindividual variability in responses to coumarins. Patient and environmental factors that affect anticoagulation response to coumarins include age, body size, dietary vitamin K status, concurrent disease and drug interactions. More recently, single nucleotide polymorphisms in the 2C9 isoform of cytochrome P450 (CYP2C9) and vitamin K epoxide reductase (VKOR) have been shown to make significant contributions to the variability in coumarin dosage requirements. Polymorphisms in other genes that mediate the actions of coumarins may also contribute to this variability. Racial and cultural differences influence dosage requirements, which can be explained, at least in part, by genetic and dietary factors. Incorporation of genetic and environmental factors could help in the prediction of more individualized loading and maintenance doses for safer anticoagulation therapy. © 2006 Blackwell Publishing Ltd.
Author(s): Kamali F, Pirmohamed M
Publication type: Review
Publication status: Published
Journal: British Journal of Clinical Pharmacology
Year: 2006
Volume: 61
Issue: 6
Pages: 746-751
ISSN (print): 0306-5251
ISSN (electronic): 1365-2125
URL: http://dx.doi.org/10.1111/j.1365-2125.2006.02679.x
DOI: 10.1111/j.1365-2125.2006.02679.x
